Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0029713 (
immaturity
)
4,335
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Neonatal B cells have been considered immature because of their impaired capacity to produce immunoglobulins in response to polyclonal activators in vitro. Here we demonstrate that cord blood mononuclear cells (MNC) produce normal levels of IgE in vitro when cultured in the presence of interleukin-4 (IL-4), indicating that the B cells are mature in their capacity to switch to IgE-producing cells. However, in contrast to adult peripheral blood T cells, cord blood T cells failed to produce detectable levels of IL-4 upon activation by phytohaemagglutinin (PHA) concanavalin A (Con A) or combinations of PHA and the phorbol ester TPA.
Interferon-gamma
(
IFN-gamma
) production by cord blood T cells following activation by Con A or PHA was also strongly reduced. However, high levels of
IFN-gamma
, significantly higher than those produced by adult T cells, were synthesized in response to combinations of PHA and TPA, indicating that
IFN-gamma
production by cord blood T cells is not intrinsically defective. In contrast, cord blood T cells produced levels of IL-2 that were significantly higher than those obtained by adult T cells tested in parallel. Collectively, our data indicate that the minimal levels of IgE production measured in cord blood (less than 1 U/ml) are not due to
immaturity
of the cord blood B cells, but may be associated with the failure of cord blood T cells to produce detectable levels of IL-4, which has been shown to be responsible for induction of IgE synthesis both in vitro and in vivo.
...
PMID:Cord blood B cells are mature in their capacity to switch to IgE-producing cells in response to interleukin-4 in vitro. 211 17
Interferon-gamma
(
IFN-gamma
), a lymphokine produced by lymphocytes with the help of monocytes, is essential for host resistance to intracellular pathogens. Leukocytes from normal term newborn infants cannot produce
IFN-gamma
in vitro in response to stimulation by antigen or mitogens in vitro or in vivo. We investigated the production of
IFN-gamma
in vitro using endotoxin from Salmonella typhimurium as a stimulus. In contrast to those from adults, mononuclear cells derived from the cord blood of newborn infants did not produce
IFN-gamma
in response to this endotoxin. We investigated the contribution of the functional
immaturity
of cord blood monocytes to this relative inability to produce
IFN-gamma
. Aging of the monocytes for 2 weeks in vitro or treatment of freshly isolated cord blood monocytes with conditioned medium (from cultures of mononuclear cells from healthy adults) greatly enhanced
IFN-gamma
production stimulated by endotoxin. Furthermore, recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF), macrophage colony-stimulating factor (M-CSF), or
IFN-gamma
was able to substitute in part for the conditioned medium from adult cells. Thus correction of the functional
immaturity
of monocytes derived from newborn infants can result in enhanced production of
IFN-gamma
in vitro.
...
PMID:Enhancement in vitro of the low interferon-gamma production of leukocytes from human newborn infants. 831 52